Abubakar, Zamesa M.

HRN: 24-83-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFTRIAXONE 1G (VIAL)
04/02/2024
04/08/2024
IV DRIP
2g
OD
Presumptive PTB; UTI
Checking Final Appropriateness 
04/07/2024
CO-AMOXICLAV 625MG (TAB)
04/07/2024
04/09/2024
ORAL
625 Mg Tablet
2x A Day
Empiric
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: